Emzotamig is a monoclonal antibody inhibitor targeting tumor necrosis factor (TNF). It holds potential for research on autoimmune diseases related to the overexpression of TNF, such as rheumatoid arthritis and ankylosing spondylitis.
CAS Number:
[3037572-57-6]
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted